Reckamp K - Search Results

1

Evaluation of Omics-Based Strategies for the Management of Advanced Lung Cancer.

Salgia R, Mambetsariev I, Pharaon R, Fricke J, Baroz AR, Hozo I, Chen C, Koczywas M, Massarelli E, Reckamp K, Djulbegovic B. Salgia R, et al. Among authors: reckamp k. JCO Oncol Pract. 2021 Feb;17(2):e257-e265. doi: 10.1200/OP.20.00117. Epub 2020 Jul 8. JCO Oncol Pract. 2021. PMID: 32639928 Free PMC article.

2

Non-small cell lung cancer in the elderly: defining treatment options.

Vora N, Reckamp KL. Vora N, et al. Semin Oncol. 2008 Dec;35(6):590-6. doi: 10.1053/j.seminoncol.2008.08.009. Semin Oncol. 2008. PMID: 19027463 Free PMC article. Review.

3

The role of targeting mammalian target of rapamycin in lung cancer.

Pal SK, Figlin RA, Reckamp KL. Pal SK, et al. Clin Lung Cancer. 2008 Nov;9(6):340-5. doi: 10.3816/CLC.2008.n.049. Clin Lung Cancer. 2008. PMID: 19073516 Review.

4

An interdisciplinary care approach for integration of palliative care in lung cancer.

Borneman T, Koczywas M, Cristea M, Reckamp K, Sun V, Ferrell B. Borneman T, et al. Among authors: reckamp k. Clin Lung Cancer. 2008 Nov;9(6):352-60. doi: 10.3816/CLC.2008.n.051. Clin Lung Cancer. 2008. PMID: 19073518

5

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer.

Reckamp KL, Figlin RA, Burdick MD, Dubinett SM, Elashoff RM, Strieter RM. Reckamp KL, et al. BMC Cancer. 2009 Jun 29;9:213. doi: 10.1186/1471-2407-9-213. BMC Cancer. 2009. PMID: 19563666 Free PMC article.

6

Targeted therapies for non-small cell lung cancer: an evolving landscape.

Pal SK, Figlin RA, Reckamp K. Pal SK, et al. Among authors: reckamp k. Mol Cancer Ther. 2010 Jul;9(7):1931-44. doi: 10.1158/1535-7163.MCT-10-0239. Epub 2010 Jun 22. Mol Cancer Ther. 2010. PMID: 20571071 Free PMC article. Review.

7

Biomarker-based phase I dose-escalation, pharmacokinetic, and pharmacodynamic study of oral apricoxib in combination with erlotinib in advanced nonsmall cell lung cancer.

Reckamp K, Gitlitz B, Chen LC, Patel R, Milne G, Syto M, Jezior D, Zaknoen S. Reckamp K, et al. Cancer. 2011 Feb 15;117(4):809-18. doi: 10.1002/cncr.25473. Epub 2010 Oct 4. Cancer. 2011. PMID: 20922800 Free article. Clinical Trial.

8

Predictors of finding benefit after lung cancer diagnosis.

Thornton AA, Owen JE, Kernstine K, Koczywas M, Grannis F, Cristea M, Reckamp K, Stanton AL. Thornton AA, et al. Among authors: reckamp k. Psychooncology. 2012 Apr;21(4):365-73. doi: 10.1002/pon.1904. Epub 2011 Jan 20. Psychooncology. 2012. PMID: 21254308

9

Management of non-small-cell lung cancer in the older adult.

VanderWalde A, Pal SK, Reckamp KL. VanderWalde A, et al. Maturitas. 2011 Apr;68(4):311-21. doi: 10.1016/j.maturitas.2011.01.008. Epub 2011 Feb 3. Maturitas. 2011. PMID: 21295421 Review.

10

A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer.

Blumenschein GR Jr, Kabbinavar F, Menon H, Mok TSK, Stephenson J, Beck JT, Lakshmaiah K, Reckamp K, Hei YJ, Kracht K, Sun YN, Sikorski R, Schwartzberg L; Motesanib NSCLC Phase II Study Investigators. Blumenschein GR Jr, et al. Among authors: reckamp k. Ann Oncol. 2011 Sep;22(9):2057-2067. doi: 10.1093/annonc/mdq731. Epub 2011 Feb 14. Ann Oncol. 2011. PMID: 21321086 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters